• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于鼻腔给药的没食子酸丙酯包封的固体脂质纳米粒负载水凝胶的研制与表征

Development and Characterization of -Propyl Gallate Encapsulated Solid Lipid Nanoparticles-Loaded Hydrogel for Intranasal Delivery.

作者信息

Sabir Fakhara, Katona Gábor, Ismail Ruba, Sipos Bence, Ambrus Rita, Csóka Ildikó

机构信息

Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Eötvös Str. 6, H-6720 Szeged, Hungary.

Department of Applied & Environmental Chemistry, Faculty of Science and Informatics, University of Szeged, Rerrich Béla sqr. 1, H-6720 Szeged, Hungary.

出版信息

Pharmaceuticals (Basel). 2021 Jul 19;14(7):696. doi: 10.3390/ph14070696.

DOI:10.3390/ph14070696
PMID:34358121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8308668/
Abstract

The objective of the present study was to develop -propyl gallate-loaded solid lipid nanoparticles (PG-SLNs) in a hydrogel (HG) formulation using Transcutol-P (TC-P) as a permeation enhancer. Modified solvent injection technique was applied to produce optimized PG-SLNs via the Quality by Design approach and central composite design. The in vitro mucoadhesion, scavenging activity, drug release, permeation studies of PG from PG-SLNs-loaded HG were evaluated under simulated nasal conditions. Compared with in vitro release behavior of PG from SLNs, the drug release from the PG-SLNs-loaded HG showed a lower burst effect and sustained release profile. The cumulative permeation of PG from PG-SLNs-loaded HG with TC-P was 600 μg/cm within 60 min, which is 3-60-fold higher than PG-SLNs and native PG, respectively. Raman mapping showed that the distribution of PG-SLNs was more concentrated in HG having lower concentrations of hyaluronic acid. The scavenging assay demonstrated increased antioxidant activity at higher concentrations of HG. Due to enhanced stability and mucoadhesive properties, the developed HG-based SLNs can improve nasal absorption by increasing residence time on nasal mucosa. This study provides in vitro proof of the potential of combining the advantages of SLNs and HG for the intranasal delivery of antioxidants.

摘要

本研究的目的是使用二乙二醇单乙基醚(Transcutol-P,TC-P)作为渗透促进剂,在水凝胶(HG)制剂中制备载有没食子酸丙酯的固体脂质纳米粒(PG-SLNs)。采用改良溶剂注入技术,通过质量源于设计方法和中心复合设计来制备优化的PG-SLNs。在模拟鼻腔条件下,对载有PG-SLNs的HG的体外黏膜黏附性、清除活性、药物释放和PG渗透进行了研究。与PG从SLNs的体外释放行为相比,载有PG-SLNs的HG的药物释放显示出较低的突释效应和缓释特性。载有PG-SLNs的HG与TC-P一起时,PG在60分钟内的累积渗透量为600μg/cm²,分别比PG-SLNs和天然PG高3至60倍。拉曼映射显示,PG-SLNs的分布在透明质酸浓度较低的HG中更为集中。清除试验表明,在较高浓度的HG下抗氧化活性增强。由于稳定性和黏膜黏附性增强,所开发的基于HG的SLNs可通过增加在鼻黏膜上的停留时间来改善鼻腔吸收。本研究提供了体外证据,证明了结合SLNs和HG的优势用于鼻内递送抗氧化剂的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e7/8308668/c50ed563075a/pharmaceuticals-14-00696-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e7/8308668/4e1aa0ad03f2/pharmaceuticals-14-00696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e7/8308668/a5581a95ee6e/pharmaceuticals-14-00696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e7/8308668/c50ed563075a/pharmaceuticals-14-00696-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e7/8308668/4e1aa0ad03f2/pharmaceuticals-14-00696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e7/8308668/a5581a95ee6e/pharmaceuticals-14-00696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e7/8308668/c50ed563075a/pharmaceuticals-14-00696-g004.jpg

相似文献

1
Development and Characterization of -Propyl Gallate Encapsulated Solid Lipid Nanoparticles-Loaded Hydrogel for Intranasal Delivery.用于鼻腔给药的没食子酸丙酯包封的固体脂质纳米粒负载水凝胶的研制与表征
Pharmaceuticals (Basel). 2021 Jul 19;14(7):696. doi: 10.3390/ph14070696.
2
Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration.基于质量源于设计的丙酸丙酯接枝透明质酸包载脂质体的研制及其经鼻给药
Molecules. 2021 Mar 6;26(5):1429. doi: 10.3390/molecules26051429.
3
Development of mirtazapine loaded solid lipid nanoparticles for topical delivery: Optimization, characterization and cytotoxicity evaluation.载米氮平固体脂质纳米粒的制备及其经皮给药系统的优化、评价。
Int J Pharm. 2020 Aug 30;586:119439. doi: 10.1016/j.ijpharm.2020.119439. Epub 2020 Jul 2.
4
A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation.美洛昔康经鼻给药中脂质体和聚合物纳米粒的对比研究:制剂、表征和体外评价。
Int J Pharm. 2021 Jul 15;604:120724. doi: 10.1016/j.ijpharm.2021.120724. Epub 2021 May 21.
5
A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.一种新型鼻腔装载阿莫曲坦固体脂质纳米粒的黏附性原位凝胶制剂用于脑部靶向:制备、表征和体内评价。
Int J Pharm. 2018 Sep 5;548(1):609-624. doi: 10.1016/j.ijpharm.2018.07.014. Epub 2018 Jul 6.
6
Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies.用于局部眼部治疗的克拉霉素固体脂质纳米粒:优化、评价及体内研究
Pharmaceutics. 2021 Apr 9;13(4):523. doi: 10.3390/pharmaceutics13040523.
7
Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.用于阿伐那非经皮递送的固体脂质纳米粒:优化、制剂、体外和离体研究
J Liposome Res. 2016 Dec;26(4):288-96. doi: 10.3109/08982104.2015.1117490. Epub 2016 Jan 19.
8
Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.载柚皮素固体脂质纳米粒:制备、控释、细胞摄取及肺部药代动力学
Drug Des Devel Ther. 2016 Mar 1;10:911-25. doi: 10.2147/DDDT.S97738. eCollection 2016.
9
Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.载紫杉醇和柚皮素的固体脂质纳米粒经环肽表面修饰后,提高了在多形性胶质母细胞瘤中的肿瘤靶向能力。
Biomed Pharmacother. 2021 Jun;138:111461. doi: 10.1016/j.biopha.2021.111461. Epub 2021 Mar 9.
10
Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.液固脂质比对用于透皮给药的氟比洛芬固体脂质纳米粒(SLNs)和纳米结构脂质载体(NLCs)特性的影响。
Drug Dev Ind Pharm. 2016 Aug;42(8):1308-14. doi: 10.3109/03639045.2015.1132226. Epub 2016 Jan 20.

引用本文的文献

1
Application of allogeneic adult mesenchymal stem cells in the treatment of venous ulcers: A phase I/II randomized controlled trial protocol.异体成人间充质干细胞在静脉溃疡治疗中的应用:一项I/II期随机对照试验方案。
PLoS One. 2025 May 15;20(5):e0323173. doi: 10.1371/journal.pone.0323173. eCollection 2025.
2
Recent Advancements in Gallic Acid-Based Drug Delivery: Applications, Clinical Trials, and Future Directions.基于没食子酸的药物递送的最新进展:应用、临床试验及未来方向。
Pharmaceutics. 2024 Sep 13;16(9):1202. doi: 10.3390/pharmaceutics16091202.
3
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport.

本文引用的文献

1
and evaluation of an ionic sensitive gel containing nanotransfersomes for aripiprazole nasal delivery.并评价了一种含有纳米转脂体的离子敏感凝胶,用于阿立哌唑的经鼻给药。
Pharm Dev Technol. 2021 Oct;26(8):867-879. doi: 10.1080/10837450.2021.1948571. Epub 2021 Jul 15.
2
Mucoadhesive and mucus-penetrating interpolyelectrolyte complexes for nose-to-brain drug delivery.用于鼻脑给药的粘膜粘附和粘液穿透性聚电解质复合物
Nanomedicine. 2021 Oct;37:102432. doi: 10.1016/j.nano.2021.102432. Epub 2021 Jun 27.
3
Enhancement of T2* Weighted MRI Imaging Sensitivity of U87MG Glioblastoma Cells Using γ-Ray Irradiated Low Molecular Weight Hyaluronic Acid-Conjugated Iron Nanoparticles.
鼻腔给药至大脑:利用纳米颗粒实现有效的药物输送。
Pharmaceutics. 2024 Apr 1;16(4):481. doi: 10.3390/pharmaceutics16040481.
4
Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems.质量源于设计理念(QbD)在水凝胶基药物递送系统研发中的应用。
Polymers (Basel). 2023 Nov 14;15(22):4407. doi: 10.3390/polym15224407.
5
Editorial-Current Insights on Lipid-Based Nanosystems.社论——基于脂质的纳米系统的当前见解
Pharmaceuticals (Basel). 2022 Oct 14;15(10):1267. doi: 10.3390/ph15101267.
6
Development of Lomustine and -Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration.洛莫司汀与没食子酸丙酯共包封脂质体经鼻内给药靶向多形性胶质母细胞瘤的研究进展
Pharmaceutics. 2022 Mar 12;14(3):631. doi: 10.3390/pharmaceutics14030631.
7
Modern Wound Dressings: Hydrogel Dressings.现代伤口敷料:水凝胶敷料。
Biomedicines. 2021 Sep 16;9(9):1235. doi: 10.3390/biomedicines9091235.
利用γ射线辐照的低相对分子质量透明质酸偶联铁纳米粒子增强 U87MG 脑胶质瘤细胞的 T2*加权 MRI 成像灵敏度。
Int J Nanomedicine. 2021 Jun 1;16:3789-3802. doi: 10.2147/IJN.S307648. eCollection 2021.
4
Chitosan derivatives-based films as pH-sensitive drug delivery systems with enhanced antioxidant and antibacterial properties.壳聚糖衍生物基薄膜作为 pH 敏感型药物传递系统,具有增强的抗氧化和抗菌性能。
Int J Biol Macromol. 2021 Jul 1;182:730-742. doi: 10.1016/j.ijbiomac.2021.04.014. Epub 2021 Apr 6.
5
Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration.基于质量源于设计的丙酸丙酯接枝透明质酸包载脂质体的研制及其经鼻给药
Molecules. 2021 Mar 6;26(5):1429. doi: 10.3390/molecules26051429.
6
An updated mode of action and human relevance framework evaluation for Formaldehyde-Related nasal tumors.更新的甲醛相关鼻肿瘤作用模式和人类相关性框架评估
Crit Rev Toxicol. 2020 Nov;50(10):919-952. doi: 10.1080/10408444.2020.1854679.
7
Synthetic ionizable aminolipids induce a pH dependent inverse hexagonal to bicontinuous cubic lyotropic liquid crystalline phase transition in monoolein nanoparticles.合成可离子化的氨基脂诱导单油酸甘油酯纳米颗粒中 pH 依赖的反向六方到双连续立方溶致液晶相转变。
J Colloid Interface Sci. 2021 May;589:85-95. doi: 10.1016/j.jcis.2020.12.060. Epub 2020 Dec 22.
8
A Proposed Methodology for a Risk Assessment-Based Liposome Development Process.一种基于风险评估的脂质体开发过程的建议方法。
Pharmaceutics. 2020 Nov 29;12(12):1164. doi: 10.3390/pharmaceutics12121164.
9
Biodegradable double cross-linked chitosan hydrogels for drug delivery: Impact of chemistry on rheological and pharmacological performance.可生物降解的双交联壳聚糖水凝胶用于药物输送:化学对流变学和药理学性能的影响。
Int J Biol Macromol. 2020 Dec 15;165(Pt B):2205-2218. doi: 10.1016/j.ijbiomac.2020.10.006. Epub 2020 Oct 12.
10
Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery.采用基于纳米技术的策略管理癫痫疾病,实现经鼻向脑递药。
Expert Opin Drug Deliv. 2021 Feb;18(2):169-185. doi: 10.1080/17425247.2021.1823965. Epub 2020 Sep 29.